Protalix BioTherapeutics, Inc. - PLX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Sep 09, 2026 | — | A | A | 8,500.0 | 0.0 | 0.0 | 8,500.0 | View | |
| Sep 09, 2026 | — | A | A | 17,000.0 | 0.0 | 0.0 | 17,000.0 | View | |
| Sep 04, 2026 | Sr. VP & COO | A | A | 56,000.0 | 0.0 | 0.0 | 56,000.0 | View | |
| Sep 04, 2026 | Sr. VP & COO | A | A | 112,000.0 | 0.0 | 0.0 | 112,000.0 | View | |
| Sep 04, 2026 | — | A | A | 8,500.0 | 0.0 | 0.0 | 8,500.0 | View | |
| Sep 04, 2026 | — | A | A | 17,000.0 | 0.0 | 0.0 | 17,000.0 | View | |
| Sep 04, 2026 | — | A | A | 8,500.0 | 0.0 | 0.0 | 8,500.0 | View | |
| Sep 04, 2026 | — | A | A | 17,000.0 | 0.0 | 0.0 | 17,000.0 | View | |
| Sep 04, 2026 | — | A | A | 8,500.0 | 0.0 | 0.0 | 8,500.0 | View | |
| Sep 04, 2026 | — | A | A | 17,000.0 | 0.0 | 0.0 | 17,000.0 | View | |
| Sep 04, 2026 | PRESIDENT AND CEO | A | A | 160,000.0 | 0.0 | 0.0 | 160,000.0 | View | |
| Sep 04, 2026 | PRESIDENT AND CEO | A | A | 320,000.0 | 0.0 | 0.0 | 320,000.0 | View | |
| Sep 04, 2026 | — | A | A | 8,500.0 | 0.0 | 0.0 | 8,500.0 | View | |
| Sep 04, 2026 | — | A | A | 17,000.0 | 0.0 | 0.0 | 17,000.0 | View | |
| Sep 04, 2026 | — | A | A | 8,500.0 | 0.0 | 0.0 | 8,500.0 | View | |
| Sep 04, 2026 | — | A | A | 17,000.0 | 0.0 | 0.0 | 17,000.0 | View | |
| Sep 04, 2026 | — | A | A | 8,500.0 | 0.0 | 0.0 | 8,500.0 | View | |
| Sep 04, 2026 | — | A | A | 17,000.0 | 0.0 | 0.0 | 17,000.0 | View |